IGC - Cannabis Based Pain Relief Solution Receives European Patent Approval | Benzinga
IGC Pharma, Inc. (NYSE American: IGC) has been granted European Patent No. 3193862 by the European Patent Office for its innovative "Cannabinoid Composition and Method for Treating Pain."
The newly granted patent introduces a pioneering method for treating pain in humans.
How It Works
Utilizing a cream base infused with a unique blend of cannabinoids, including tetrahydrocannabinol (THC) and cannabidiol (CBD) as well as other compounds, the cream or gel is designed for transdermal absorption.
It interacts harmoniously with the peripheral nervous and immune systems, effectively relieving pain without psychotropic or adverse side effects.
Recent consumer trends indicate a profound demand for safe and effective pain relief, and IGC Pharma is seeking to advance pain relief therapies, said Ram Mukunda, the company's CEO.
"We aspire to redefine the standard for pain management, providing healthier alternatives ...